SUPN
Supernus Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +2 | 42.40M | $1.97B | +5 | −5 |
| Q1 2026 | 104 | -3 | 41.20M | $2.13B | +5 | −9 |
| Q4 2025 | 107 | 0 | 43.16M | $2.15B | +1 | n/a |
| Q3 2025 | 18 | -1 | 27.64M | $1.32B | n/a | −2 |
| Q2 2025 | 17 | 0 | 22.78M | $717.88M | n/a | n/a |
| Q1 2025 | 14 | 0 | 6.75M | $221.22M | n/a | n/a |
| Q4 2024 | 14 | 0 | 6.49M | $234.56M | +1 | −1 |
| Q3 2024 | 13 | 0 | 4.54M | $141.67M | +1 | −1 |
| Q2 2024 | 13 | n/a | 4.27M | $114.18M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 1.69M | n/a | $45.08M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.41M | n/a | $37.66M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | D. E. Shaw & Co. ✦ | 290.80K | n/a | $7.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (pasivo) | 208.84K | n/a | $5.59M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 161.33K | n/a | $4.32M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 142.93K | n/a | $3.82M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Point72 Asset Management ✦ | 136.34K | n/a | $3.65M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 73.52K | n/a | $1.97M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 48.56K | n/a | $1.30M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 47.52K | n/a | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 40.68K | n/a | $1.09M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 12 | AQR Capital Management ✦ | 13.95K | n/a | $373,269 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 13 | Gotham Asset Management ✦ | 11.05K | n/a | $295,614 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 323 tenedores, 57.94M acciones, $2.88B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.